The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of first-line treatments for patients (pts) with advanced EGFR mutated NSCLC: Network meta-analysis of TKI monotherapy and combinations trials.
 
Alexey Bogdanov
No Relationships to Disclose
 
Fedor Vladimirovich Moiseenko
Honoraria - AstraZeneca; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; MSD Oncology; Novartis; Pfizer/EMD Serono; Roche; Sanofi/Aventis; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Roche; Takeda
Research Funding - BioCad (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Sanofi/Aventis
Other Relationship - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD Oncology; Pfizer (Inst); Roche
 
Albina Zhabina
No Relationships to Disclose
 
Nikita Volkov
Speakers' Bureau - AstraZeneca; BioCad; Sanofi/Aventis
Travel, Accommodations, Expenses - Roche (Inst)
 
Elizaveta Artem'eva
No Relationships to Disclose
 
Mikhail Fedyanin
No Relationships to Disclose